WAVE Life Sciences

WVE · NASDAQ

$3.42+$0.25 (+7.89%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $3.17

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. The company employs 317 full-time employees The company went IPO on 2015-11-11. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Employees: 317
Headquarters: Singapore
Listed: Nov 11, 2015
Sector: Health Care
Industry: Pharmaceuticals
Website: wavelifesciences.com

Leadership

WAVE Life Sciences executives
Name	Title	Since	Age
Christian Henry	—	—	57
Paul Bolno	—	2013	51
Kyle Moran	—	—	54
Christopher Francis	—	—	47
Chandra Vargeese	—	—	63
Christopher Wright	—	—	59
Gregory Verdine	—	—	65
Mark Corrigan	—	—	67
Peter Kolchinsky	—	—	48
Adrian Rawcliffe	—	—	52
Ken Takanashi	—	—	60
Aik Na Tan	—	—	54
Heidi Wagner	—	—	60
Kate Rausch	—	2018	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

WAVE Life Sciences suppliers and customers
Company	Relationship	Country	Correlation
Bio-Techne TECH	Supplier and customer	US	0.50
Takeda Pharmaceutical	Supplier and customer	JP	0.47
IRBM SpA	Supplier and customer	IT	—
University College London	Supplier and customer	GB	—
University of Louisville	Supplier and customer	US	—
University of Massachusetts Medical School	Supplier and customer	US	—
University of Oxford	Supplier and customer	GB	—
Western Washington University	Supplier and customer	US	—

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.